Biotech Industry News

A collection of Biotech latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

bizjournals.com - Don Seiffert - Biotech upsizes target for pending IPO to $250M
Biotech upsizes target for pending IPO to $250M
The Business Journals

By Don Seiffert – Managing Editor, Boston Business Journal Boston-based Bicara Therapeutics, which had been aiming to raise $212 million in an initial public offering, said late Wednesday that it will now aim to sell even more shares to…

abcnews.go.com -  DIDI TANG and HAVEN DALEY Associated Press - Congress targets Chinese influence in health tech. It could come with tradeoffs
Congress targets Chinese influence in health tech. It could come with tradeoffs
ABC News

WASHINGTON -- A California biotechnology company that helps doctors detect genetic causes for cancer is among those that could be cut out of the U.S. market over ties to China, underscoring the possible tradeoffs between health innovation and a…

ibtimes.co.uk - London Biotechnology Show Makes Grand Return To Unveil Cutting-edge Advances in Health & Medicine
London Biotechnology Show Makes Grand Return To Unveil Cutting-edge Advances in Health & Medicine
International Business Times UK

The London Biotechnology Show, which returns on 18-19 June 2025 at Excel London, is set to surpass the success of its debut edition. This year's event has grown significantly, offering a wider range of content, product showcases, and innovations…

fool.com - Prosper Junior Bakiny - 1 Biotech Stock Down 62% to Buy and Hold | The Motley Fool
1 Biotech Stock Down 62% to Buy and Hold | The Motley Fool
https://www.fool.com/

In the past three years, CRISPR Therapeutics (CRSP -0.33%) has made tremendous progress. It was still a clinical-stage biotech in 2021, but it now has a gene-editing therapy that is approved in multiple countries. However, this regulatory milestone…

business-standard.com - Press Trust of India - Bio-E3 policy to usher in bio-revolution in India: Jitendra Singh
Bio-E3 policy to usher in bio-revolution in India: Jitendra Singh
Business Standard

The government's Bio-E3 policy marks a crucial step in positioning India as a global bio-economy leader and is set to spark a 'bio-revolution' in India similar to the IT revolution in the western world, Union minister Jitendra Singh said on…

business-standard.com - Press Trust of India - Need innovation-driven value creation in biotech: Kiran Mazumdar-Shaw
Need innovation-driven value creation in biotech: Kiran Mazumdar-Shaw
Business Standard

Biocon Chairperson Kiran Mazumdar-Shaw on Thursday called for more investment in research and development to drive innovation and foster culture of intellectual property. She highlighted how the country, already the world's largest exporter of…

globenewswire.com - Chemometec A/S - Notification of managers' transactions
Notification of managers' transactions
GlobeNewswire

Notification of managers' transactions ChemoMetec A/S has received the enclosed notification pursuant to Article 19 of EU Regulation no. 596/2014 of transactions related to shares in ChemoMetec A/S made by persons discharging managerial…

yorkpress.co.uk - Darren Greenwood - York biotech firm hopes for success with deodorants
York biotech firm hopes for success with deodorants
York Press

The partnership began in 2022 and has been further extended following successful lab tests at both companies. Dr Arron Tolley, Chief Executive Officer of Aptamer Group, said: “The continued advancement of our Optimer binders in collaboration…

cnbc.com - Annika Kim Constantino - Moderna to cut $1.1 billion in costs and launch 10 new products by 2027 as it charts post-Covid future
Moderna to cut $1.1 billion in costs and launch 10 new products by 2027 as it charts post-Covid future
CNBC

Moderna said it plans to cut $1.1 billion in expenses by 2027 as it charts a path forward after the rapid decline of its Covid business. The biotech company said it expects 10 new product approvals through 2027. But Moderna is also deprioritizing…

bizjournals.com - Hannah Green - Petri Dish: Novartis' $320M deal with Voyager; Cellino gets ARPA-H money - Boston Business Journal
Petri Dish: Novartis' $320M deal with Voyager; Cellino gets ARPA-H money - Boston Business Journal
The Business Journals

The summer's slower funding environment has given way to a rush of announcements so far in September. Over the past week, a Cambridge company won funding from the Advanced Research Projects Agency for Health, and two Massachusetts medical device…

marketwatch.com - Health Care Up on Cyclical Bias -- Health Care Roundup
Health Care Up on Cyclical Bias -- Health Care Roundup
MarketWatch

Health-care companies rose, but not by as much as the broad market, as traders rotated into cyclical sectors. Pfizer shares fell after The Wall Street Journal reported that a key heart drug, marketed under the brand names Vyndaqel and Vyndamax…

bloomberg.com - China Woos Global Drugmakers With Promise of Swift Approvals
China Woos Global Drugmakers With Promise of Swift Approvals
Bloomberg

China invites global drugmakers to set up production units Ease of access follows US move to check Chinese biotech firms China is wooing global pharmaceutical giants with the pledge of faster approvals for innovative medicines and local production…

forbes.com - Brendan Ahern - China Market Update: Alibaba, Tencent, & Meituan Are Buying Their Stock. Are You?
China Market Update: Alibaba, Tencent, & Meituan Are Buying Their Stock. Are You?
Forbes

Asian equities were higher except for Mainland China on light volumes and little news as the US dollar strengthened overnight. Hong Kong grinded higher, led by volume leader Alibaba, following an interesting day in US-listed China ADRs yesterday…

abcnews.go.com -  DIDI TANG and ELSIE CHEN Associated Press - US House clears a largely bipartisan package of bills to counter China
US House clears a largely bipartisan package of bills to counter China
ABC News

WASHINGTON -- The U.S. House this week approved a sweeping package of bills to counter China's influence, shoring up a largely bipartisan push to ensure America comes out ahead in the competition between the world's superpowers. The efforts would…

wsj.com - Health Care Roundup: Market Talk
Health Care Roundup: Market Talk
Wall Street Journal

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 0718 GMT – Innovent Biologics could post a revenue CAGR of 30% over 2023-2028, due to its continuing new…

Receive a Daily briefing on Biotech Industry News

Get Started